Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators?
Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators? Nat Clin Pract Oncol. 2006 Mar; 3(3):134-5.